Fibroblast Growth Factor 21 (FGF-21) in Peritoneal Dialysis Patients: Natural History and Metabolic Implications

about

Association between circulating fibroblast growth factor 21 and mortality in end-stage renal disease.

P2860

Q33764747-217452DB-F859-4398-82A7-03BE8A84C308

P2860

Fibroblast Growth Factor 21 (FGF-21) in Peritoneal Dialysis Patients: Natural History and Metabolic Implications

Item

http://www.wikidata.org/entity/Q35960914

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Fibroblast Growth Factor 21 (F ...... ory and Metabolic Implications

@ast

Fibroblast Growth Factor 21 (F ...... ory and Metabolic Implications

@en

type

Item

label

Fibroblast Growth Factor 21 (F ...... ory and Metabolic Implications

@ast

Fibroblast Growth Factor 21 (F ...... ory and Metabolic Implications

@en

prefLabel

Fibroblast Growth Factor 21 (F ...... ory and Metabolic Implications

@ast

Fibroblast Growth Factor 21 (F ...... ory and Metabolic Implications

@en

P1476

Fibroblast Growth Factor 21 (F ...... ory and Metabolic Implications

@en

P2093

Cristina Grande

http://www.w3.org/2001/XMLSchema#string

Gloria del Peso

http://www.w3.org/2001/XMLSchema#string

Juan J Díez

http://www.w3.org/2001/XMLSchema#string

M Auxiliadora Bajo

http://www.w3.org/2001/XMLSchema#string

Mariana Díaz-Almirón

http://www.w3.org/2001/XMLSchema#string

Olaia Rodríguez

http://www.w3.org/2001/XMLSchema#string

Pedro Iglesias

http://www.w3.org/2001/XMLSchema#string

Rafael Selgas

http://www.w3.org/2001/XMLSchema#string

P2860

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

Circulating FGF21 levels are progressively increased from the early to end stages of chronic kidney diseases and are associated with renal function in Chinese

Strategies to reduce glucose exposure in peritoneal dialysis patients.

Fibroblast growth factor 21: effects on carbohydrate and lipid metabolism in health and disease.

Safety issues of long-term glucose load in patients on peritoneal dialysis--a 7-year cohort study.

Relationship of serum fibroblast growth factor 21 with abnormal glucose metabolism and insulin resistance: the Baltimore Longitudinal Study of Aging.

Serum fibroblast growth factor 21 is associated with renal function and chronic kidney disease in community-dwelling adults.

Reduced residual renal function is associated with endothelial dysfunction in patients receiving peritoneal dialysis.

FGFs and metabolism.

FGF10 and FGF21 as regulators in adipocyte development and metabolism.

P304

e0151698

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0151698

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Elena González

P577

2016-03-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

298797656

http://www.w3.org/2001/XMLSchema#string

P698

26986485

http://www.w3.org/2001/XMLSchema#string

P921

renal dialysis

P932

4795603

http://www.w3.org/2001/XMLSchema#string

Fibroblast Growth Factor 21 (FGF-21) in Peritoneal Dialysis Patients: Natural History and Metabolic Implications

about

P2860

P2860

Fibroblast Growth Factor 21 (FGF-21) in Peritoneal Dialysis Patients: Natural History and Metabolic Implications

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698

P921

P932